Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Aadi Bioscience raises $23mm in Series A round

Executive Summary

Aadi Bioscience Inc. (oncology- and cardiovascular-focused biopharma) raised $23mm in its Series A financing round led by Hermed Capital and with participation from Celgene Corp., Vivo Capital, Decheng Capital, the Helsinn Investment Fund, and Star Summit Ventures. Carlo Montagner (Specialised Therapeutics), Richard Maroun (Frazier Healthcare Partners), Jerry Xiao (Hermed Capital), and Mahendra Shah (Vivo Capital) joined the company's board.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Nanotechnology, Chips, etc.
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register